Opiant Pharmaceuticals (OPNT) Tops Q4 EPS by 18c
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Financial Fact:
Sales and marketing: 15.24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Sales and marketing: 15.24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Opiant Pharmaceuticals (NASDAQ: OPNT) reported Q4 EPS of $0.17, $0.18 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $13.26 million.
For earnings history and earnings-related data on Opiant Pharmaceuticals (OPNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
